Skip to main content
. 2003 Mar 7;138(5):959–967. doi: 10.1038/sj.bjp.0705121

Figure 1.

Figure 1

Pretreatment with nafamostat mesilate and gabexate mesilate reverses the ioxaglate-induced pulmonary vascular hyperpermeability in rats. Nafamostat mesilate and gabexate mesilate were injected i.v. 5 min before intravenous injection of ioxaglate (4 g iodine kg−1). Vascular permeability was assessed by the extravasation of Evans blue dye to lung tissues 10 min after ioxaglate injection. Each column represents the mean±s.e.mean. Number of animals was shown in each parenthesis. *P<0.05, **P<0.01 versus control.